SCHEMBL18312911

SCHEMBL18312911

CCOC(=O)c1cn(-c2ccccc2Cl)c2nc(Cl)ccc2c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 6/20 0.47
LMNA P02545 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 3/20 0.47
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
PDE4B Q07343 1/20 0.45
PIM1 P11309 1/20 0.45
IRAK1 P51617 1/20 0.45
CAMK2B Q13554 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18312882 0.89 ALDH1A1 (0.50) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL18312920 0.89 ALDH1A1 (0.56) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL18313515 0.87 KDM4E (0.46) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL22432852 0.86 ALDH1A1 (0.52) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL19784021 0.85 ALDH1A1 (0.44) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL18312907 0.85 MAPT (0.47) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL18306081 0.85 GABRA2 (0.39) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL20531668 0.85 ALDH1A1 (0.50) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL20532009 0.83 ALDH1A1 (0.46) TDP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL18305929 0.83 TSHR (0.42) ALDH1A1LMNAMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107949562-B Positive allosteric modulators of muscarinic M2 receptors 拜耳制药股份公司 2021-07-23 CN disclosed
EP-3307741-B1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARIC M2 RECEPTOR Bayer Pharma AG (DE) 2020-10-28 EP disclosed
EP-3692991-A1 POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC M2 RECEPTOR Bayer Pharma Aktiengesellschaft (DE) 2020-08-12 EP disclosed
US-10435403-B2 Positive allosteric modulators of muscarinic M2 receptor BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-10-08 US disclosed
US-10435403-B2 Positive allosteric modulators of muscarinic M2 receptor BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2019-10-08 US disclosed
US-20180297994-A1 POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-10-18 US disclosed
WO-2016198342-A1 POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180297994-A1 POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR CHRM2, CHRM1, CHRM3 TDP1 3412/4885ALDH1A1 4456/4885LMNA 4169/4885
US-10435403-B2 Positive allosteric modulators of muscarinic M2 receptor CHRM2, CHRM1, CHRM3 TDP1 3412/4885ALDH1A1 4456/4885LMNA 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.